Immunology

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 14: Zeile 14:
 
{{tp|p=32436320|t=2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.|pdf=|usr=007}}
 
{{tp|p=32436320|t=2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.|pdf=|usr=007}}
 
{{tp|p=32506725|t=2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.|pdf=|usr=007}}
 
{{tp|p=32506725|t=2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.|pdf=|usr=007}}
 +
{{tp|p=32529906|t=2020. Serological differentiation between COVID-19 and SARS infections.|pdf=|usr=008}}
 +
{{tp|p=32380903|t=2020. Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2.|pdf=|usr=008}}
 +
{{tp|p=32426212|t=2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.|pdf=|usr=008}}
 +
{{tp|p=32526272|t=2020. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.|pdf=|usr=008}}
 +
  
  
Zeile 22: Zeile 27:
 
{{tp|p=32418947|t=2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?|pdf=|usr=007}}
 
{{tp|p=32418947|t=2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?|pdf=|usr=007}}
 
{{tp|p=32372779|t=2020. Do you become immune once you have been infected?|pdf=|usr=}}
 
{{tp|p=32372779|t=2020. Do you become immune once you have been infected?|pdf=|usr=}}
 +
{{tp|p=32433946|t=2020. Herd Immunity: Understanding COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32509257|t=2020. SARS-CoV-2, "common cold" coronaviruses' cross-reactivity and "herd immunity": The razor of Ockham (1285-1347)?|pdf=|usr=008}}
 +
 +
  
 
===Neutralizing antibodies===
 
===Neutralizing antibodies===
Zeile 28: Zeile 37:
 
{{tp|p=32497196|t=2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.|pdf=|usr=007}}
 
{{tp|p=32497196|t=2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.|pdf=|usr=007}}
 
{{ttp|p=32073157|t=2020. Antibodies to coronaviruses are higher in older compared with younger adults and  binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |pdf=|usr=}}
 
{{ttp|p=32073157|t=2020. Antibodies to coronaviruses are higher in older compared with younger adults and  binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |pdf=|usr=}}
 +
{{tp|p=32515685|t=2020. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.|pdf=|usr=008}}
 +
  
 
===Innate sensing===
 
===Innate sensing===
Zeile 38: Zeile 49:
 
{{tp|p=32456409|t=2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.|pdf=|usr=007}}
 
{{tp|p=32456409|t=2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.|pdf=|usr=007}}
 
{{ttp|p=32156572|t=2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation |pdf=|usr=}}
 
{{ttp|p=32156572|t=2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation |pdf=|usr=}}
 +
{{ttp|p=32454408|t=2020. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.|pdf=|usr=008}}
 +
{{tp|p=32524333|t=2020. COVID 19: a clue from innate immunity.|pdf=|usr=008}}
 +
{{tp|p=32464098|t=2020. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?|pdf=|usr=008}}
 +
  
 
===integrative work===
 
===integrative work===
Zeile 58: Zeile 73:
 
{{tp|p=32498686|t=2020. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32498686|t=2020. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32514817|t=2020. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32514817|t=2020. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.|pdf=|usr=008}}
 +
{{tp|p=32460144|t=2020. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions.|pdf=|usr=008}}
 +
{{tp|p=32417709|t=2020. Mechanism of inflammatory response in associated comorbidities in COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32444400|t=2020. COVID-19 and the nicotinic cholinergic system.|pdf=|usr=008}}
 +
{{tp|p=32413330|t=2020. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.|pdf=|usr=008}}
 +
{{tp|p=32514174|t=2020. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32489708|t=2020. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
 +
{{tp|p=32396996|t=2020. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.|pdf=|usr=008}}
 +
{{ttp|p=32454136|t=2020. The role of IgA in COVID-19.|pdf=|usr=008}}
 +
{{ttp|p=32526273|t=2020. A plea for the pathogenic role of immune complexes in severe Covid-19.|pdf=|usr=008}}
 +
  
 
===covid modulates the immune system===
 
===covid modulates the immune system===
 +
{{ttp|p=32514047|t=2020. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).|pdf=|usr=008}}
 +
{{ttp|p=32479746|t=2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.|pdf=|usr=008}}
 +
{{ttp|p=32529952|t=2020. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.|pdf=|usr=008}}
 
{{tp|p=32364527|t=2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32364527|t=2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32172672|t=2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |pdf=|usr=}}
 
{{tp|p=32172672|t=2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |pdf=|usr=}}
Zeile 72: Zeile 100:
 
{{tp|p=32514592|t=2020. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.|pdf=|usr=008}}
 
{{tp|p=32514592|t=2020. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.|pdf=|usr=008}}
 
{{tp|p=32456696|t=2020. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients.|pdf=|usr=008}}
 
{{tp|p=32456696|t=2020. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients.|pdf=|usr=008}}
−
 
+
{{tp|p=32502135|t=2020. Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.|pdf=|usr=008}}
 +
{{tp|p=32532524|t=2020. SARS-CoV-2-A Tough Opponent for the Immune System.|pdf=|usr=008}}
 +
{{tp|p=32416070|t=2020. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32513989|t=2020. The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.|pdf=|usr=008}}
  
  
Zeile 107: Zeile 138:
 
{{tp|p=32474608|t=2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.|pdf=|usr=007}}
 
{{tp|p=32474608|t=2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.|pdf=|usr=007}}
 
{{tp|p=32483488|t=2020. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32483488|t=2020. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.|pdf=|usr=008}}
−
 
+
{{tp|p=32382776|t=2020. Signals of Th2 immune response from COVID-19 patients requiring intensive care.|pdf=|usr=008}}
 +
{{tp|p=32417210|t=2020. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?|pdf=|usr=008}}
 +
{{tp|p=32405080|t=2020. Decreased T cell populations contribute to the increased severity of COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32407466|t=2020. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.|pdf=|usr=008}}
  
 
===t cell exhaustion===
 
===t cell exhaustion===
Zeile 117: Zeile 151:
 
{{ttp|p=32203186|t=2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |pdf=|usr=}}
 
{{ttp|p=32203186|t=2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |pdf=|usr=}}
 
{{tp|p=32414395|t=2020. COVID-19: room for treating T cell exhaustion?|pdf=|usr=008}}
 
{{tp|p=32414395|t=2020. COVID-19: room for treating T cell exhaustion?|pdf=|usr=008}}
 +
{{tp|p=32425950|t=2020. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
 +
 +
  
  
Zeile 154: Zeile 191:
 
{{tp|p=32383183|t=2020. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.|pdf=|usr=008}}{{tp|p=32521002|t=2020. Antibody profiles in mild and severe cases of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32383183|t=2020. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.|pdf=|usr=008}}{{tp|p=32521002|t=2020. Antibody profiles in mild and severe cases of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32399213|t=2020. Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.|pdf=|usr=008}}
 
{{tp|p=32399213|t=2020. Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.|pdf=|usr=008}}
 +
{{tp|p=32515684|t=2020. Patterns of IgG and IgM antibody response in COVID-19 patients.|pdf=|usr=008}}
 +
{{ttp|p=32425955|t=2020. Potential SARS-CoV-2 Preimmune IgM Epitopes.|pdf=|usr=008}}
 +
{{tp|p=32439770|t=2020. T cells found in coronavirus patients 'bode well' for long-term immunity.|pdf=|usr=008}}
 +
{{ttp|p=32473127|t=2020. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.|pdf=|usr=008}}
 +
{{tp|p=32513850|t=2020. Early Insights into Immune Responses during COVID-19.|pdf=|usr=008}}
  
  
Zeile 159: Zeile 201:
 
===antiviral mediators===
 
===antiviral mediators===
 
{{tp|p=32422144|t=2020. Perforin and resistance to SARS coronavirus 2.|pdf=|usr=008}}
 
{{tp|p=32422144|t=2020. Perforin and resistance to SARS coronavirus 2.|pdf=|usr=008}}
 +
{{ttp|p=32437749|t=2020. Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.|pdf=|usr=008}}
 +
  
 
===mediators===
 
===mediators===
Zeile 168: Zeile 212:
 
{{ttp|p=32421281|t=2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?|pdf=|usr=007}}
 
{{ttp|p=32421281|t=2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?|pdf=|usr=007}}
 
{{tp|p=32437622|t=2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.|pdf=|usr=007}}
 
{{tp|p=32437622|t=2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32475759|t=2020. IL-6: Relevance for immunopathology of SARS-CoV-2.|pdf=|usr=008}}
 +
 +
  
 
===immunopathology===
 
===immunopathology===
Zeile 192: Zeile 239:
 
{{tp|p=32422146|t=2020. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.|pdf=|usr=008}}
 
{{tp|p=32422146|t=2020. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.|pdf=|usr=008}}
 
{{tp|p=32521376|t=2020. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.|pdf=|usr=008}}
 
{{tp|p=32521376|t=2020. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.|pdf=|usr=008}}
 +
{{tp|p=32470851|t=2020. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis.|pdf=|usr=008}}
 +
{{tp|p=32454103|t=2020. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection.|pdf=|usr=008}}
 +
{{tp|p=32398804|t=2020. Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?|pdf=|usr=008}}
  
  
Zeile 201: Zeile 251:
 
{{tp|p=32389543|t=ä. COVID-19 and molecular mimicry: The Columbus? egg?|pdf=|usr=}}
 
{{tp|p=32389543|t=ä. COVID-19 and molecular mimicry: The Columbus? egg?|pdf=|usr=}}
 
{{tp|p=32444414|t=2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.|pdf=|usr=007}}
 
{{tp|p=32444414|t=2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.|pdf=|usr=007}}
 +
{{ttp|p=32535095|t=2020. Molecular mimicry may explain multi-organ damage in COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32535093|t=2020. Covid-19 and autoimmunity.|pdf=|usr=008}}
 +
{{tp|p=32461193|t=2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.|pdf=|usr=008}}
  
  
Zeile 220: Zeile 273:
 
{{tp|p=32497191|t=2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.|pdf=|usr=007}}
 
{{tp|p=32497191|t=2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.|pdf=|usr=007}}
 
{{ttp|p=32426999|t=2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.|pdf=|usr=007}}
 
{{ttp|p=32426999|t=2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.|pdf=|usr=007}}
−
 
+
{{tp|p=32432790|t=2020. Editorial - COVID-19 and the microbiota: new kids on the block.|pdf=|usr=008}}
−
===008===
+
{{tp|p=32442562|t=2020. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.|pdf=|usr=008}}
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
  
  
 +
'''some other papers'''
 +
{{tp|p=32215589|t=2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia |pdf=|usr=}}
 
{{tp|p=32504103|t=2020. Ten things we learned about COVID-19.|pdf=|usr=008}}
 
{{tp|p=32504103|t=2020. Ten things we learned about COVID-19.|pdf=|usr=008}}
 
{{tp|p=32494929|t=2020. COVID-19: 10 things I wished I'd known some months ago.|pdf=|usr=008}}
 
{{tp|p=32494929|t=2020. COVID-19: 10 things I wished I'd known some months ago.|pdf=|usr=008}}
−
 
−
 
−
{{tp|p=32422376|t=2020. Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report.|pdf=|usr=008}}
 
−
{{tp|p=32437934|t=2020. Use of anakinra in severe COVID-19: a case report.|pdf=|usr=008}}
 
−
 
 
{{tp|p=32437740|t=2020. The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32437740|t=2020. The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China.|pdf=|usr=008}}
−
 
−
 
−
 
−
 
−
 
−
 
−
 
−
 
−
 
 
{{tp|p=32510470|t=2020. Is innate immunity our best weapon for flattening the curve?|pdf=|usr=008}}
 
{{tp|p=32510470|t=2020. Is innate immunity our best weapon for flattening the curve?|pdf=|usr=008}}
−
 
−
 
−
 
−
 
 
{{tp|p=32464309|t=2020. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients.|pdf=|usr=008}}
 
{{tp|p=32464309|t=2020. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients.|pdf=|usr=008}}
−
 
−
 
 
{{tp|p=32398780|t=2020. The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection.|pdf=|usr=008}}
 
{{tp|p=32398780|t=2020. The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection.|pdf=|usr=008}}
−
 
 
{{tp|p=32534002|t=2020. Cancer population may be paradoxically protected from severe manifestations of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32534002|t=2020. Cancer population may be paradoxically protected from severe manifestations of COVID-19.|pdf=|usr=008}}
−
 
−
 
 
{{tp|p=32360499|t=2020. Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions.|pdf=|usr=008}}
 
{{tp|p=32360499|t=2020. Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions.|pdf=|usr=008}}
 
{{tp|p=32283147|t=2020. Prolonged virus shedding even after seroconversion in a patient with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32283147|t=2020. Prolonged virus shedding even after seroconversion in a patient with COVID-19.|pdf=|usr=008}}
−
 
+
{{ttp|p=32461703|t=2020. Mechanobiology predicts raft formations triggered by ligand-receptor activity across the cell membrane.|pdf=|usr=008}}
−
 
+
−
 
+
−
{{tp|p=32461703|t=2020. Mechanobiology predicts raft formations triggered by ligand-receptor activity across the cell membrane.|pdf=|usr=008}}
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
{{tp|p=32159234|t=2020. Identification of coronavirus sequences in carp cDNA from Wuhan, China.|pdf=|usr=008}}
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
 
+
−
{{tp|p=32384917|t=2020. COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.|pdf=|usr=008}}
+
−
 
+
−
 
+
−
 
+
−
 
+
−
{{tp|p=32517773|t=2020. Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32499988|t=2020. Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines.|pdf=|usr=008}}
+
−
{{tp|p=32416074|t=2020. A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein.|pdf=|usr=008}}
+
−
{{tp|p=32460144|t=2020. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions.|pdf=|usr=008}}
+
−
{{tp|p=32522400|t=2020. Letter to the Editor on "Bonafe M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev".|pdf=|usr=008}}
+
−
{{tp|p=32513566|t=2020. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.|pdf=|usr=008}}
+
−
{{tp|p=32475759|t=2020. IL-6: Relevance for immunopathology of SARS-CoV-2.|pdf=|usr=008}}
+
−
{{tp|p=32446778|t=2020. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.|pdf=|usr=008}}
+
−
{{tp|p=32389499|t=2020. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes.|pdf=|usr=008}}
+
−
{{tp|p=32421092|t=2020. SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc.|pdf=|usr=008}}
+
−
{{tp|p=32470851|t=2020. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis.|pdf=|usr=008}}
+
−
{{tp|p=32417709|t=2020. Mechanism of inflammatory response in associated comorbidities in COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32517769|t=2020. Histopathology of COVID-19 pneumonia in two non-oncological, non-hospitalised cases as a reliable diagnostic benchmark.|pdf=|usr=008}}
+
 
{{tp|p=32412125|t=2020. Androgen sensitivity gateway to COVID-19 disease severity.|pdf=|usr=008}}
 
{{tp|p=32412125|t=2020. Androgen sensitivity gateway to COVID-19 disease severity.|pdf=|usr=008}}
−
{{tp|p=32454408|t=2020. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.|pdf=|usr=008}}
 
 
{{tp|p=32393438|t=2020. Intelligent classification of platelet aggregates by agonist type.|pdf=|usr=008}}
 
{{tp|p=32393438|t=2020. Intelligent classification of platelet aggregates by agonist type.|pdf=|usr=008}}
−
{{tp|p=32529906|t=2020. Serological differentiation between COVID-19 and SARS infections.|pdf=|usr=008}}
 
−
{{tp|p=32529952|t=2020. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.|pdf=|usr=008}}
 
−
{{tp|p=32525765|t=2020. Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries.|pdf=|usr=008}}
 
−
{{tp|p=32515685|t=2020. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32515684|t=2020. Patterns of IgG and IgM antibody response in COVID-19 patients.|pdf=|usr=008}}
 
−
{{tp|p=32380903|t=2020. Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2.|pdf=|usr=008}}
 
−
{{tp|p=32533508|t=2020. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32419876|t=2020. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictive, preventive, and personalized medical approach.|pdf=|usr=008}}
 
 
{{tp|p=32444797|t=2020. BBMRI-ERIC's contributions to research and knowledge exchange on COVID-19.|pdf=|usr=008}}
 
{{tp|p=32444797|t=2020. BBMRI-ERIC's contributions to research and knowledge exchange on COVID-19.|pdf=|usr=008}}
 
{{tp|p=32415272|t=2020. Connecting data, tools and people across Europe: ELIXIR's response to the COVID-19 pandemic.|pdf=|usr=008}}
 
{{tp|p=32415272|t=2020. Connecting data, tools and people across Europe: ELIXIR's response to the COVID-19 pandemic.|pdf=|usr=008}}
−
{{tp|p=32404885|t=2020. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.|pdf=|usr=008}}
 
 
{{tp|p=32376989|t=2020. The VODAN IN: support of a FAIR-based infrastructure for COVID-19.|pdf=|usr=008}}
 
{{tp|p=32376989|t=2020. The VODAN IN: support of a FAIR-based infrastructure for COVID-19.|pdf=|usr=008}}
 
{{tp|p=32335973|t=2020. Of mice and men: COVID-19 challenges translational neuroscience.|pdf=|usr=008}}
 
{{tp|p=32335973|t=2020. Of mice and men: COVID-19 challenges translational neuroscience.|pdf=|usr=008}}
−
{{tp|p=32444400|t=2020. COVID-19 and the nicotinic cholinergic system.|pdf=|usr=008}}
 
−
{{tp|p=32398299|t=2020. To compare the incomparable: COVID-19 pneumonia and high altitude disease.|pdf=|usr=008}}
 
−
{{tp|p=32432790|t=2020. Editorial - COVID-19 and the microbiota: new kids on the block.|pdf=|usr=008}}
 
−
{{tp|p=32432787|t=2020. SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy.|pdf=|usr=008}}
 
−
{{tp|p=32524957|t=2020. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020.|pdf=|usr=008}}
 
−
{{tp|p=32524946|t=2020. Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020.|pdf=|usr=008}}
 
−
{{tp|p=32474064|t=2020. A novel cell-based assay for dynamically detecting neutrophil extracellular traps-induced lung epithelial injuries.|pdf=|usr=008}}
 
−
{{tp|p=32454103|t=2020. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection.|pdf=|usr=008}}
 
−
{{tp|p=32489244|t=2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.|pdf=|usr=008}}
 
−
{{tp|p=32399755|t=2020. A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32425955|t=2020. Potential SARS-CoV-2 Preimmune IgM Epitopes.|pdf=|usr=008}}
 
−
{{tp|p=32425950|t=2020. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
 
−
{{tp|p=32391299|t=2020. COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children.|pdf=|usr=008}}
 
−
{{tp|p=32442562|t=2020. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.|pdf=|usr=008}}
 
−
{{tp|p=32413354|t=2020. Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease.|pdf=|usr=008}}
 
−
{{tp|p=32437749|t=2020. Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.|pdf=|usr=008}}
 
−
{{tp|p=32445924|t=2020. Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution.|pdf=|usr=008}}
 
 
{{tp|p=32510005|t=2020. COVID-19 target: A specific target for novel coronavirus detection.|pdf=|usr=008}}
 
{{tp|p=32510005|t=2020. COVID-19 target: A specific target for novel coronavirus detection.|pdf=|usr=008}}
 
{{tp|p=32526937|t=2020. Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak.|pdf=|usr=008}}
 
{{tp|p=32526937|t=2020. Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak.|pdf=|usr=008}}
−
{{tp|p=32520981|t=2020. ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2.|pdf=|usr=008}}
 
−
{{tp|p=32504168|t=2020. Impact of glycoscience in fighting Covid-19.|pdf=|usr=008}}
 
−
{{tp|p=32522249|t=2020. Genomics of COVID-19: molecular mechanisms going from susceptibility to severity of the disease.|pdf=|usr=008}}
 
 
{{tp|p=32437706|t=2020. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.|pdf=|usr=008}}
 
{{tp|p=32437706|t=2020. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.|pdf=|usr=008}}
−
{{tp|p=32483525|t=2020. A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm).|pdf=|usr=008}}
 
−
{{tp|p=32433946|t=2020. Herd Immunity: Understanding COVID-19.|pdf=|usr=008}}
 
 
{{tp|p=32392464|t=2020. SARS-CoV-2: Combating Coronavirus Emergence.|pdf=|usr=008}}
 
{{tp|p=32392464|t=2020. SARS-CoV-2: Combating Coronavirus Emergence.|pdf=|usr=008}}
−
{{tp|p=32497522|t=2020. Respiratory Virus Infections: Understanding COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32413330|t=2020. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.|pdf=|usr=008}}
 
−
{{tp|p=32534867|t=2020. Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1'-phosphatase.|pdf=|usr=008}}
 
−
{{tp|p=32524333|t=2020. COVID 19: a clue from innate immunity.|pdf=|usr=008}}
 
 
{{tp|p=32473952|t=2020. SARS-CoV-2: The viral shedding vs infectivity dilemma.|pdf=|usr=008}}
 
{{tp|p=32473952|t=2020. SARS-CoV-2: The viral shedding vs infectivity dilemma.|pdf=|usr=008}}
−
{{tp|p=32509257|t=2020. SARS-CoV-2, "common cold" coronaviruses' cross-reactivity and "herd immunity": The razor of Ockham (1285-1347)?|pdf=|usr=008}}
 
−
{{tp|p=32474891|t=2020. COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia.|pdf=|usr=008}}
 
−
{{tp|p=32473977|t=2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.|pdf=|usr=008}}
 
−
{{tp|p=32473976|t=2020. SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.|pdf=|usr=008}}
 
−
{{tp|p=32473352|t=2020. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.|pdf=|usr=008}}
 
 
{{tp|p=32450246|t=2020. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience.|pdf=|usr=008}}
 
{{tp|p=32450246|t=2020. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience.|pdf=|usr=008}}
 
{{tp|p=32405281|t=2020. Sars-CoV-2 and black population: ACE2 as shield or blade?|pdf=|usr=008}}
 
{{tp|p=32405281|t=2020. Sars-CoV-2 and black population: ACE2 as shield or blade?|pdf=|usr=008}}
−
{{tp|p=32502733|t=2020. Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach.|pdf=|usr=008}}
 
 
{{tp|p=32524515|t=2020. Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.|pdf=|usr=008}}
 
{{tp|p=32524515|t=2020. Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.|pdf=|usr=008}}
−
{{tp|p=32532942|t=2020. MERS-CoV and SARS-CoV infections in animals: a systematic review and meta-analysis of prevalence studies.|pdf=|usr=008}}
 
−
{{tp|p=32529477|t=2020. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".|pdf=|usr=008}}
 
−
{{tp|p=32501423|t=2020. Developing an ultra-efficient microsatellite discoverer to find structural differences between SARS-CoV-1 and Covid-19.|pdf=|usr=008}}
 
−
{{tp|p=32531713|t=2020. Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32437920|t=2020. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line.|pdf=|usr=008}}
 
−
{{tp|p=32534186|t=2020. Procalcitonin levels in COVID-19 patients.|pdf=|usr=008}}
 
 
{{tp|p=32485251|t=2020. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32485251|t=2020. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.|pdf=|usr=008}}
−
{{tp|p=32516845|t=2020. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32530491|t=2020. Presepsin as a predictive biomarker of severity in COVID-19: A case series.|pdf=|usr=008}}
 
−
{{tp|p=32519791|t=2020. Hypoalbuminaemia in COVID-19 infection: A predictor of severity or a potential therapeutic target?|pdf=|usr=008}}
 
−
{{tp|p=32519786|t=2020. Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection.|pdf=|usr=008}}
 
−
{{tp|p=32519768|t=2020. Hyperpyrexia in COVID-19 patients.|pdf=|usr=008}}
 
−
{{tp|p=32526083|t=2020. Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32530583|t=2020. Neuropathological Features of Covid-19.|pdf=|usr=008}}
 
−
{{tp|p=32534467|t=2020. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.|pdf=|usr=008}}
 
−
{{tp|p=32515386|t=2020. Glucovigilance in COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32515374|t=2020. The Microbiology of Coronaviruses.|pdf=|usr=008}}
 
 
{{tp|p=31896597|t=2020. Host AAA+ ATPase TER94 Plays Critical Roles in Building the Baculovirus Viral Replication Factory and Virion Morphogenesis.|pdf=|usr=008}}
 
{{tp|p=31896597|t=2020. Host AAA+ ATPase TER94 Plays Critical Roles in Building the Baculovirus Viral Replication Factory and Virion Morphogenesis.|pdf=|usr=008}}
−
{{tp|p=32518411|t=2020. Genomic search for COVID-19 severity clues.|pdf=|usr=008}}
 
−
{{tp|p=32514174|t=2020. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.|pdf=|usr=008}}
 
 
{{tp|p=32528156|t=2020. Ten recommendations for supporting open pathogen genomic analysis in public health.|pdf=|usr=008}}
 
{{tp|p=32528156|t=2020. Ten recommendations for supporting open pathogen genomic analysis in public health.|pdf=|usr=008}}
−
{{tp|p=32528149|t=2020. Kawasaki disease in a COVID-19-struck region.|pdf=|usr=008}}
 
−
{{tp|p=32427517|t=2020. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.|pdf=|usr=008}}
 
−
{{tp|p=32533838|t=2020. The pathological autopsy of coronavirus disease 2019 (COVID-2019) in China: a review.|pdf=|usr=008}}
 
−
{{tp|p=32527802|t=2020. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.|pdf=|usr=008}}
 
−
{{tp|p=32467368|t=2020. Doctors race to understand inflammatory condition in kids.|pdf=|usr=008}}
 
 
{{tp|p=32467367|t=2020. Scientists put survivors' blood plasma to the test.|pdf=|usr=008}}
 
{{tp|p=32467367|t=2020. Scientists put survivors' blood plasma to the test.|pdf=|usr=008}}
−
{{tp|p=32439770|t=2020. T cells found in coronavirus patients 'bode well' for long-term immunity.|pdf=|usr=008}}
 
−
{{tp|p=32527928|t=2020. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.|pdf=|usr=008}}
 
−
{{tp|p=32527925|t=2020. Type III interferons disrupt the lung epithelial barrier upon viral recognition.|pdf=|usr=008}}
 
−
{{tp|p=32526773|t=2020. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.|pdf=|usr=008}}
 
−
{{tp|p=32513613|t=2020. COVID-19 and the ABO blood group connection.|pdf=|usr=008}}
 
−
===007===
 
−
'''some other papers'''
 
 
{{tp|p=32496715|t=2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]|pdf=|usr=007}}
 
{{tp|p=32496715|t=2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]|pdf=|usr=007}}
 
{{tp|p=32455617|t=2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.|pdf=|usr=007}}
 
{{tp|p=32455617|t=2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.|pdf=|usr=007}}
Zeile 419: Zeile 313:
 
{{tp|p=32470223|t=2020. COVID-19: Structural Predictions of Viral Success.|pdf=|usr=007}}
 
{{tp|p=32470223|t=2020. COVID-19: Structural Predictions of Viral Success.|pdf=|usr=007}}
 
{{tp|p=32423901|t=2020. How covid-19 is accelerating the threat of antimicrobial resistance.|pdf=|usr=007}}
 
{{tp|p=32423901|t=2020. How covid-19 is accelerating the threat of antimicrobial resistance.|pdf=|usr=007}}
−
{{tp|p=32413176|t=2020. The emergence of methemoglobinemia amidst the COVID-19 pandemic.|pdf=|usr=007}}
 
 
{{tp|p=32504123|t=2020. COVID-19 research: toxicological input urgently needed!|pdf=|usr=007}}
 
{{tp|p=32504123|t=2020. COVID-19 research: toxicological input urgently needed!|pdf=|usr=007}}
 
{{tp|p=32412787|t=2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.|pdf=|usr=007}}
 
{{tp|p=32412787|t=2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.|pdf=|usr=007}}
 
{{tp|p=32213337|t=ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort  study |pdf=|usr=}}
 
{{tp|p=32213337|t=ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort  study |pdf=|usr=}}
−
{{tp|p=32215589|t=2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia |pdf=|usr=}}
 
 
{{tp|p=32360743|t=ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19 |pdf=|usr=}}
 
{{tp|p=32360743|t=ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19 |pdf=|usr=}}
 
{{tp|p=32292530|t=2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan|pdf=|usr=}}
 
{{tp|p=32292530|t=2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan|pdf=|usr=}}
Zeile 431: Zeile 323:
 
{{ttp|p=32359201|t=2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures |pdf=|usr=}}
 
{{ttp|p=32359201|t=2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures |pdf=|usr=}}
 
{{tp|p=32376309|t=2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients |pdf=|usr=}}
 
{{tp|p=32376309|t=2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients |pdf=|usr=}}
−
{{tp|p=32132669|t=ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV |pdf=|usr=}}
 
 
{{tp|p=32388390|t=2020. The powerful immune system against powerful COVID-19: A hypothesis |pdf=|usr=}}
 
{{tp|p=32388390|t=2020. The powerful immune system against powerful COVID-19: A hypothesis |pdf=|usr=}}
 
{{tp|p=32372807|t=2020. The fever paradox |pdf=|usr=}}
 
{{tp|p=32372807|t=2020. The fever paradox |pdf=|usr=}}
−
 
−
{{tp|p=32449057|t=2020. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.|pdf=|usr=008}}
 
 
{{tp|p=32220035|t=2020. SARS-CoV-2: What do we know so far?|pdf=|usr=008}}
 
{{tp|p=32220035|t=2020. SARS-CoV-2: What do we know so far?|pdf=|usr=008}}
 
{{tp|p=32534452|t=2020. From causes of aging to death from COVID-19.|pdf=|usr=008}}
 
{{tp|p=32534452|t=2020. From causes of aging to death from COVID-19.|pdf=|usr=008}}
−
{{tp|p=32339157|t=2020. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32489708|t=2020. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
 
 
{{tp|p=32489698|t=2020. COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.|pdf=|usr=008}}
 
{{tp|p=32489698|t=2020. COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.|pdf=|usr=008}}
 
{{tp|p=32401346|t=2020. SARS-CoV-2 immunogenicity at the crossroads.|pdf=|usr=008}}
 
{{tp|p=32401346|t=2020. SARS-CoV-2 immunogenicity at the crossroads.|pdf=|usr=008}}
−
{{tp|p=32396996|t=2020. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.|pdf=|usr=008}}
 
 
{{tp|p=32053148|t=2020. Three Emerging Coronaviruses in Two Decades.|pdf=|usr=008}}
 
{{tp|p=32053148|t=2020. Three Emerging Coronaviruses in Two Decades.|pdf=|usr=008}}
−
{{tp|p=32475764|t=2020. An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients.|pdf=|usr=008}}
 
−
{{tp|p=32513452|t=2020. Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli.|pdf=|usr=008}}
 
−
{{tp|p=32471782|t=2020. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department.|pdf=|usr=008}}
 
−
{{tp|p=32471783|t=2020. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32425320|t=2020. Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32532619|t=2020. Toxic shock-like syndrome and COVID-19: A case report of multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=008}}
 
−
{{tp|p=32405074|t=2020. Visualization of SARS-CoV-2 virus invading the human placenta using electron microscopy.|pdf=|usr=008}}
 
−
{{tp|p=32533928|t=2020. Letter-to-the-Editor: Alternative Interpretation to the Findings Reported in Visualization of SARS-CoV-2 Virus Invading the Human Placenta Using Electron Microscopy.|pdf=|usr=008}}
 
−
{{tp|p=32391518|t=2020. Detection of SARS-COV-2 in Placental and Fetal Membrane Samples.|pdf=|usr=008}}
 
−
{{tp|p=32427221|t=2020. Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth.|pdf=|usr=008}}
 
−
{{tp|p=32471774|t=2020. SARS-CoV-2: Naso-bronchial cytological correlations.|pdf=|usr=008}}
 
 
{{tp|p=32516444|t=2020. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32516444|t=2020. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32439309|t=2020. Revision narrativa sobre la respuesta inmunitaria frente a coronavirus: descripcion general, aplicabilidad para SARS-COV-2 e implicaciones terapeuticas.|pdf=|usr=008}}
 
{{tp|p=32439309|t=2020. Revision narrativa sobre la respuesta inmunitaria frente a coronavirus: descripcion general, aplicabilidad para SARS-COV-2 e implicaciones terapeuticas.|pdf=|usr=008}}
−
{{tp|p=32505756|t=2020. Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.|pdf=|usr=008}}
+
 
−
{{tp|p=32505755|t=2020. Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.|pdf=|usr=008}}
+
−
{{tp|p=32526061|t=2020. Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection.|pdf=|usr=008}}
+
−
{{tp|p=32502135|t=2020. Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.|pdf=|usr=008}}
+
−
{{tp|p=32458111|t=2020. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.|pdf=|usr=008}}
+
−
{{tp|p=32414383|t=2020. Plasma CRP level is positively associated with the severity of COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32387855|t=2020. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients.|pdf=|usr=008}}
+
−
{{tp|p=32462329|t=2020. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32500224|t=2020. Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report.|pdf=|usr=008}}
+
−
{{tp|p=32495027|t=2020. Hematological findings in coronavirus disease 2019: indications of progression of disease.|pdf=|usr=008}}
+
−
{{tp|p=32529285|t=2020. SARS-CoV-2 infection in children with febrile neutropenia.|pdf=|usr=008}}
+
−
{{tp|p=32529284|t=2020. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.|pdf=|usr=008}}
+
−
{{tp|p=32382776|t=2020. Signals of Th2 immune response from COVID-19 patients requiring intensive care.|pdf=|usr=008}}
+
−
{{tp|p=32436075|t=2020. Microvascular alterations in patients with SARS-COV-2 severe pneumonia.|pdf=|usr=008}}
+
−
{{tp|p=32488505|t=2020. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children.|pdf=|usr=008}}
+
−
{{tp|p=32422085|t=2020. Cytokine Levels in the Body Fluids of a Patient With COVID-19 and Acute Respiratory Distress Syndrome: A Case Report.|pdf=|usr=008}}
+
−
{{tp|p=32527868|t=2020. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.|pdf=|usr=008}}
+
−
{{tp|p=32395525|t=2020. A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection.|pdf=|usr=008}}
+
−
{{tp|p=32405117|t=2020. Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.|pdf=|usr=008}}
+
−
{{tp|p=32532524|t=2020. SARS-CoV-2-A Tough Opponent for the Immune System.|pdf=|usr=008}}
+
−
{{tp|p=32493627|t=2020. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.|pdf=|usr=008}}
+
−
{{tp|p=32471702|t=2020. Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?|pdf=|usr=008}}
+
−
{{tp|p=32471703|t=2020. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room.|pdf=|usr=008}}
+
−
{{tp|p=32419712|t=2020. COVID-19 and Dysfunctional Endothelium: The Mexican Scenario.|pdf=|usr=008}}
+
−
{{tp|p=32535095|t=2020. Molecular mimicry may explain multi-organ damage in COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32535093|t=2020. Covid-19 and autoimmunity.|pdf=|usr=008}}
+
−
{{tp|p=32410735|t=2020. Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.|pdf=|usr=008}}
+
−
{{tp|p=32485205|t=2020. The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.|pdf=|usr=008}}
+
−
{{tp|p=32479856|t=2020. SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention.|pdf=|usr=008}}
+
−
{{tp|p=32480226|t=2020. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections.|pdf=|usr=008}}
+
−
{{tp|p=32425294|t=2020. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.|pdf=|usr=008}}
+
−
{{tp|p=32407552|t=2020. Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient.|pdf=|usr=008}}
+
−
{{tp|p=32529634|t=2020. Haemophagocytosis in bone marrow aspirates in patients with COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32526046|t=2020. Secondary HLH is uncommon in severe COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32446945|t=2020. Do matrix metalloproteases mediate the SARS-CoV-2-related damage to the central nervous system?|pdf=|usr=008}}
+
−
{{tp|p=32454136|t=2020. The role of IgA in COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32512702|t=2020. COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.|pdf=|usr=008}}
+
−
{{tp|p=32479746|t=2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.|pdf=|usr=008}}
+
−
{{tp|p=32492406|t=2020. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.|pdf=|usr=008}}
+
−
{{tp|p=32416070|t=2020. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32413319|t=2020. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.|pdf=|usr=008}}
+
−
{{tp|p=32526206|t=2020. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.|pdf=|usr=008}}
+
−
{{tp|p=32526208|t=2020. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.|pdf=|usr=008}}
+
−
{{tp|p=32516571|t=2020. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.|pdf=|usr=008}}
+
−
{{tp|p=32473127|t=2020. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.|pdf=|usr=008}}
+
−
{{tp|p=32425270|t=2020. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells.|pdf=|usr=008}}
+
−
{{tp|p=32405102|t=2020. A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.|pdf=|usr=008}}
+
−
{{tp|p=32514047|t=2020. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).|pdf=|usr=008}}
+
−
{{tp|p=32513989|t=2020. The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.|pdf=|usr=008}}
+
−
{{tp|p=32499922|t=2020. ACE2 expression and sex disparity in COVID-19.|pdf=|usr=008}}
+
−
{{tp|p=32485164|t=2020. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.|pdf=|usr=008}}
+
−
{{tp|p=32464098|t=2020. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?|pdf=|usr=008}}
+
−
{{tp|p=32415260|t=2020. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.|pdf=|usr=008}}
+
−
{{tp|p=32398804|t=2020. Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?|pdf=|usr=008}}
+
−
{{tp|p=32426212|t=2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.|pdf=|usr=008}}
+
−
{{tp|p=32531208|t=2020. Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2.|pdf=|usr=008}}
+
 
{{tp|p=32458383|t=2020. On barring the vascular gateway against severe COVID-19 disease.|pdf=|usr=008}}
 
{{tp|p=32458383|t=2020. On barring the vascular gateway against severe COVID-19 disease.|pdf=|usr=008}}
−
{{tp|p=32500379|t=2020. COVID-19 and heme oxygenase: novel insight into the disease and potential therapies.|pdf=|usr=008}}
 
−
{{tp|p=32454047|t=2020. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32417210|t=2020. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?|pdf=|usr=008}}
 
−
{{tp|p=32405080|t=2020. Decreased T cell populations contribute to the increased severity of COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32531257|t=2020. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.|pdf=|usr=008}}
 
−
{{tp|p=32531256|t=2020. Cytokine Storm Induced by SARS-CoV-2.|pdf=|usr=008}}
 
−
{{tp|p=32461193|t=2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.|pdf=|usr=008}}
 
−
{{tp|p=32526273|t=2020. A plea for the pathogenic role of immune complexes in severe Covid-19.|pdf=|usr=008}}
 
−
{{tp|p=32407466|t=2020. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32454188|t=2020. Correlation between viral RNA shedding and serum antibodies in individuals with coronavirus disease 2019.|pdf=|usr=008}}
 
−
{{tp|p=32447048|t=2020. SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples.|pdf=|usr=008}}
 
 
{{tp|p=32526483|t=2020. COVID 19 and brain crosstalks.|pdf=|usr=008}}
 
{{tp|p=32526483|t=2020. COVID 19 and brain crosstalks.|pdf=|usr=008}}
−
{{tp|p=32525600|t=2020. Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes.|pdf=|usr=008}}
 
−
{{tp|p=32535877|t=2020. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).|pdf=|usr=008}}
 
−
{{tp|p=32533690|t=2020. Placental Pathology in COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32432897|t=2020. Reply: COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency.|pdf=|usr=008}}
 
−
{{tp|p=32432896|t=2020. Respiratory Mechanics and Gas Exchange in COVID-19 Associated Respiratory Failure.|pdf=|usr=008}}
 
−
{{tp|p=32432895|t=2020. COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency.|pdf=|usr=008}}
 
−
{{tp|p=32434816|t=2020. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?|pdf=|usr=008}}
 
−
{{tp|p=32524832|t=2020. Is Albumin Predictor of Mortality in COVID-19?|pdf=|usr=008}}
 
−
{{tp|p=32531085|t=2020. C1-INH and the contact system in COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32533986|t=2020. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.|pdf=|usr=008}}
 
−
{{tp|p=32526272|t=2020. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.|pdf=|usr=008}}
 
 
{{tp|p=32533824|t=2020. Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32533824|t=2020. Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.|pdf=|usr=008}}
−
{{tp|p=32517505|t=2020. C3 polymorphisms represent an important immunological confounder on the spread and outcome of COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32518941|t=2020. Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics.|pdf=|usr=008}}
 
−
{{tp|p=32522666|t=2020. How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?|pdf=|usr=008}}
 
−
{{tp|p=32526370|t=2020. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?|pdf=|usr=008}}
 
−
{{tp|p=32525565|t=2020. Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients.|pdf=|usr=008}}
 
 
{{tp|p=32425712|t=2020. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.|pdf=|usr=008}}
 
{{tp|p=32425712|t=2020. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.|pdf=|usr=008}}
−
{{tp|p=32535977|t=2020. Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome.|pdf=|usr=008}}
 
−
{{tp|p=32513850|t=2020. Early Insights into Immune Responses during COVID-19.|pdf=|usr=008}}
 
−
{{tp|p=32526012|t=2020. ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19.|pdf=|usr=008}}
 
−
 
−
{{tp|p=32515982|t=2020. H2S as a potential defence against COVID-19?|pdf=|usr=008}}
 
−
{{tp|p=32526026|t=2020. Hypersegmented granulocytes and COVID-19 infection.|pdf=|usr=008}}
 

Version vom 27. Juni 2020, 16:16 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Antibody-dependent enhancement


32361326 2020. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.

32504046 2020. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.
32092539 2020. Is COVID-19 receiving ADE from other coronaviruses?


32268188 ä. It is too soon to attribute ADE to COVID-19

31826992 2020. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
antibodies target one serotype of viruses but only subneutralize another, leading to antibody-dependend enhancement of the latter viruses.
32317716 ä. The potential danger of suboptimal antibody responses in COVID-19
ade


32346094 ä. COVID-19 vaccine design: the Janus face of immune enhancement
32303697 ä. Will we see protection or reinfection in COVID-19?
32438257 2020. SARS-CoV-2 and enhancing antibodies

32408068 2020. What about the original antigenic sin of the humans versus SARS-CoV-2?
the term «original antigenic sin» (OAS) was coined by T. Francis Jr at the Michigan University in the late 1950s to describe patterns of antibody response to influenza vaccination...


32436320 2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
32506725 2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.
32529906 2020. Serological differentiation between COVID-19 and SARS infections.
32380903 2020. Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2.
32426212 2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
32526272 2020. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.


Herd immunity


32438622 2020. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.
32391855 2020. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
32510562 2020. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
32418947 2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?
32372779 2020. Do you become immune once you have been infected?
32433946 2020. Herd Immunity: Understanding COVID-19.
32509257 2020. SARS-CoV-2, "common cold" coronaviruses' cross-reactivity and "herd immunity": The razor of Ockham (1285-1347)?


Neutralizing antibodies


32454513 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection.
32454512 2020. A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.
32497196 2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.

32073157 2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses


32515685 2020. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.


Innate sensing

32291557 ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells


32198201 2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
32374430 2020. DC/L-SIGNs of Hope in the COVID-19 Pandemic
32361001 ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
32248387 ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution

32407669 ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients


32456409 2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.

32156572 2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation
32454408 2020. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.


32524333 2020. COVID 19: a clue from innate immunity.
32464098 2020. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?


integrative work


32205856 2020. COVID-19 infection: the perspectives on immune responses
32359396 ä. A Dynamic Immune Response Shapes COVID-19 Progression
C7064018 ä. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

C7200337 ä. Immunology of COVID-19: current state of the science


32505227 2020. Immunology of COVID-19: Current State of the Science.
32469225 2020. COVID-19 and the immune system.

32436629 2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.


32507543 2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.

32504757 2020. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.


32493812 2020. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
32470151 2020. The perplexing question of trained immunity versus adaptive memory in COVID-19.
32472706 2020. The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.
32213336 ä. SARS-CoV-2: virus dynamics and host response
32437933 2020. Viral dynamics in asymptomatic patients with COVID-19.
32407836 2020. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.
32498686 2020. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
32514817 2020. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
32460144 2020. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions.
32417709 2020. Mechanism of inflammatory response in associated comorbidities in COVID-19.
32444400 2020. COVID-19 and the nicotinic cholinergic system.
32413330 2020. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
32514174 2020. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
32489708 2020. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19).
32396996 2020. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.

32454136 2020. The role of IgA in COVID-19.
32526273 2020. A plea for the pathogenic role of immune complexes in severe Covid-19.


covid modulates the immune system

32514047 2020. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
32479746 2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
32529952 2020. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.


32364527 2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
32172672 2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
32315725 ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China

32355328 ä. Impaired interferon signature in severe COVID-19


32375560 2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study
32376308 ä. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

32236983 2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection
32286536 ä. Coronaviruses hijack the complement system
host complement activator MASP2 as a target of the N protein of all three viruses


32463803 2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
32492165 2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
32514592 2020. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.
32456696 2020. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients.
32502135 2020. Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.
32532524 2020. SARS-CoV-2-A Tough Opponent for the Immune System.
32416070 2020. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
32513989 2020. The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.


immune cell subpopulations


32282871 ä. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19)
32325421 2020. Increased expression of CD8 marker on T-cells in COVID-19 patients
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32346099 ä. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients
32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
32228226 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
32196410 2020. Hypothesis for potential pathogenesis of SARS-CoV-2 infection?a review of immune changes in patients with viral pneumonia
32333914 ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia
32344320 ä. The clinical course and its correlated immune status in COVID-19 pneumonia
32325129 ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia
32283159 ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
32227123 ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
32343510 2020. COVID-19: are T lymphocytes simply watching?
32379887 ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19
32297671 2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
32352397 2020. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
32379199 2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes
32296069 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
32407057 2020. Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series.
32297828 2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
32370466 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32114745 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

32376308 2020. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis


32458561 2020. Lymphopenia in COVID-19: Therapeutic opportunities.
32420610 2020. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
32470153 2020. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
32474608 2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.
32483488 2020. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.
32382776 2020. Signals of Th2 immune response from COVID-19 patients requiring intensive care.
32417210 2020. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
32405080 2020. Decreased T cell populations contribute to the increased severity of COVID-19.
32407466 2020. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.

t cell exhaustion


32249845 ä. Fighting COVID-19 exhausts T cells
32479985 2020. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.

32203188 ä. Functional exhaustion of antiviral lymphocytes in COVID-19 patients
32203186 ä. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
32203188 2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients
32203186 2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients


32414395 2020. COVID-19: room for treating T cell exhaustion?
32425950 2020. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).



nk cells


32382127 ä. NKG2A and COVID-19: another brick in the wall
32344314 2020. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents


plasmacytoid dendritic cells


32298486 2020. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19)


antiviral immune response


32280952 ä. Good IgA bad IgG in SARS-CoV-2 infection?
32353870 2020. The many faces of the anti-COVID immune response
32358956 ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19
31981224 2020. Coronavirus infections and immune responses
32198005 2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic
32284614 ä. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
32355329 ä. SARS-CoV-2-reactive T cells in patients and healthy donors
32346091 ä. Neutralizing antibody response in mild COVID-19
32356908 2020. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis

32343415 2020. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients


32330332 2020. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic
32267987 2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS
32348715 2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020
32382126 ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients
32200654 2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
32476607 2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.
32449333 2020. (+)Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.
32430094 2020. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
32467617 2020. Serum IgA, IgM, and IgG responses in COVID-19.

32467616 2020. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells.
32463434 2020. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.


32398307 2020. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
32425634 2020. The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection.
32383183 2020. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.
32521002 2020. Antibody profiles in mild and severe cases of COVID-19.
32399213 2020. Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.
32515684 2020. Patterns of IgG and IgM antibody response in COVID-19 patients.

32425955 2020. Potential SARS-CoV-2 Preimmune IgM Epitopes.


32439770 2020. T cells found in coronavirus patients 'bode well' for long-term immunity.

32473127 2020. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.


32513850 2020. Early Insights into Immune Responses during COVID-19.


antiviral mediators


32422144 2020. Perforin and resistance to SARS coronavirus 2.

32437749 2020. Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.


mediators


32360285 ä. Type I IFN immunoprofiling in COVID-19 patients

32376393 ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
32305501 ä. The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement


30715745 2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study
32414693 2020. Interleukin-6 levels in children developing SARS-CoV-2 infection

32421281 2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?


32437622 2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.
32475759 2020. IL-6: Relevance for immunopathology of SARS-CoV-2.


immunopathology


32371101 ä. The correlation between SARS-CoV-2 infection and rheumatic disease
32205186 2020. COVID-19 infection and rheumatoid arthritis: Faraway, so close!
32308263 2020. CoViD-19 Immunopathology and Immunotherapy
32320677 ä. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32282863 ä. Molecular immune pathogenesis and diagnosis of COVID-19
32321823 2020. COVID-19: an Immunopathological View
32273594 ä. COVID-19: immunopathology and its implications for therapy
32303696 ä. Macrophages: a Trojan horse in COVID-19?

32376901 ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages


32423059 2020. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.
32485101 2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
32423917 2020. COVID-19 as an Acute Inflammatory Disease.

32512289 2020. Neutralizing antibodies mediate virus-immune pathology of COVID-19.


32398875 2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.
32391668 2020. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].

32498376 2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.


32460357 2020. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.

32492530 2020. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.


32389590 2020. COVID-19: Unanswered questions on immune response and pathogenesis.
32422146 2020. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
32521376 2020. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.
32470851 2020. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis.
32454103 2020. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection.
32398804 2020. Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?


secondary autoimmunity


32292901 2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity
32220633 2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
32315487 2020. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19

32314313 2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?


32389543 ä. COVID-19 and molecular mimicry: The Columbus? egg?
32444414 2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.

32535095 2020. Molecular mimicry may explain multi-organ damage in COVID-19.


32535093 2020. Covid-19 and autoimmunity.
32461193 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.


Thymus


32340873 ä. Reply: Thymopoiesis, inflamm-aging, and COVID-19 phenotype
32317217 ä. Role of thymopoiesis and inflamm-aging in COVID-19 phenotype


Eosinopenia, Eosinophilia


32368728 ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study
32344056 ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination
32369190 2020. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series

32315429 ä. Eosinophil count in severe coronavirus disease 2019 (COVID-19)


32315421 ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)
32390402 2020. SARS-CoV-2 and Eosinophilia.


microbiome


32497191 2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.

32426999 2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.


32432790 2020. Editorial - COVID-19 and the microbiota: new kids on the block.
32442562 2020. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.


some other papers
32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32504103 2020. Ten things we learned about COVID-19.
32494929 2020. COVID-19: 10 things I wished I'd known some months ago.
32437740 2020. The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China.
32510470 2020. Is innate immunity our best weapon for flattening the curve?
32464309 2020. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients.
32398780 2020. The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection.
32534002 2020. Cancer population may be paradoxically protected from severe manifestations of COVID-19.
32360499 2020. Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions.
32283147 2020. Prolonged virus shedding even after seroconversion in a patient with COVID-19.

32461703 2020. Mechanobiology predicts raft formations triggered by ligand-receptor activity across the cell membrane.


32412125 2020. Androgen sensitivity gateway to COVID-19 disease severity.
32393438 2020. Intelligent classification of platelet aggregates by agonist type.
32444797 2020. BBMRI-ERIC's contributions to research and knowledge exchange on COVID-19.
32415272 2020. Connecting data, tools and people across Europe: ELIXIR's response to the COVID-19 pandemic.
32376989 2020. The VODAN IN: support of a FAIR-based infrastructure for COVID-19.
32335973 2020. Of mice and men: COVID-19 challenges translational neuroscience.
32510005 2020. COVID-19 target: A specific target for novel coronavirus detection.
32526937 2020. Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak.
32437706 2020. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.
32392464 2020. SARS-CoV-2: Combating Coronavirus Emergence.
32473952 2020. SARS-CoV-2: The viral shedding vs infectivity dilemma.
32450246 2020. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience.
32405281 2020. Sars-CoV-2 and black population: ACE2 as shield or blade?
32524515 2020. Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.
32485251 2020. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.
31896597 2020. Host AAA+ ATPase TER94 Plays Critical Roles in Building the Baculovirus Viral Replication Factory and Virion Morphogenesis.
32528156 2020. Ten recommendations for supporting open pathogen genomic analysis in public health.
32467367 2020. Scientists put survivors' blood plasma to the test.
32496715 2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]
32455617 2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.
32512133 2020. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.
32512089 2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.
32470223 2020. COVID-19: Structural Predictions of Viral Success.
32423901 2020. How covid-19 is accelerating the threat of antimicrobial resistance.
32504123 2020. COVID-19 research: toxicological input urgently needed!
32412787 2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.
32213337 ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
32360743 ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19
32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan
32346093 ä. The trinity of COVID-19: immunity, inflammation and intervention
32348636 2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva
32235915 ä. COVID-19: a new challenge for human beings

32359201 2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures


32376309 2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
32388390 2020. The powerful immune system against powerful COVID-19: A hypothesis
32372807 2020. The fever paradox
32220035 2020. SARS-CoV-2: What do we know so far?
32534452 2020. From causes of aging to death from COVID-19.
32489698 2020. COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.
32401346 2020. SARS-CoV-2 immunogenicity at the crossroads.
32053148 2020. Three Emerging Coronaviruses in Two Decades.
32516444 2020. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.
32439309 2020. Revision narrativa sobre la respuesta inmunitaria frente a coronavirus: descripcion general, aplicabilidad para SARS-COV-2 e implicaciones terapeuticas.


32458383 2020. On barring the vascular gateway against severe COVID-19 disease.
32526483 2020. COVID 19 and brain crosstalks.
32533824 2020. Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.
32425712 2020. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Von „http://coviki.org/cov/index.php?title=Immunology&oldid=3124“
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis